Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Category Archives: Androgel

Subscribe to Androgel RSS Feed

FDA: AndroGel, Low-T Drugs Must Warn for Heart Attack

Posted in Androgel

On Tuesday March 3rd, the United States Food and Drug Administration required that manufacturers of testosterone supplements (or, Low-T drugs)  include warnings on packaging for the increased risk for heart attack and stroke linked to these drugs. In years past, a great many peer-reviewed scientific studies had demonstrated that men using Low-T drugs were at… Continue Reading

2014 – Study shows 54% increased risk for cardiovascular side effects with AndroGel

Posted in Androgel

According to a recent article published in Current Opinion in Endocrinology, Diabetes, and Obesity by CM Schooling titled “Testosterone and cardiovascular disease.”,  there is a clear link between use of testosterone supplements such as AndroGel and increased risk for heart attack. Schooling (2014) writes, “Use of testosterone among men is increasing rapidly. Low serum testosterone… Continue Reading

How Testosterone Affects the Heart and Poses Risk

Posted in Androgel

In recent years, several important studies have shown that testosterone therapy is associated with an increased risk for heart attack, stroke, and even death, especially in older men.  Mainly, these studies have proposed, but not detailed, the biochemical mechanism by which increases in testosterone levels may pose these such risks, and this was not their… Continue Reading

2010 – Four times as many adverse cardiac events in AndroGel users vs. placebo

Posted in Androgel

In 2010, a study was published in The New England Journal of Medicine titled “Adverse events associated with testosterone administration.” by S. Basaria and a team of researchers, aiming to further clarify adverse events associated with testosterone therapy.  Currently, testosterone therapy is provided in the treatment of “Low-T” and other ailments, many in the medical… Continue Reading

2013 – Independent studies show two-fold increased risk for adverse cardiac events with testosterone therapy

Posted in Androgel

In the April, 2013 edition of BMC Medicine, L. Xu et al. published the results of a study titled “Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.”.  This study sought to assess the relative safety of testosterone therapy with respect to adverse cardiac events.  The research team… Continue Reading

2013 – Elevated risk for heart attack, stroke in testosterone therapy

Posted in Androgel

In 2013, a team of medical researchers led by R. Vigen from The University of Texas at Southwestern Medical Center in Dallas published a report titled “Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.” in JAMA that aimed to evaluate the connection between testosterone therapy and increased… Continue Reading

2014 – Risk for heart attack 36% higher among testosterone therapy patients

Posted in Androgel

In 2014, a paper was published in the medical journal PLoS One by WD Finkle et al. titled “Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men.” studied the risk for heart attack suffered by users of testosterone therapy. The authors state “An association between testosterone therapy (TT) and cardiovascular disease has… Continue Reading

AndroGel and False Claims of Low Testosterone: Dying to be a Man…Literally

Posted in Androgel

The alpha-male. It’s a term traditionally used to describe an individual male mammal that is considered to hold the highest social standing in his community. Typically, an animal rises to alpha-male status by exhibiting signs of masculinity, confidence, and aggression to his peers. In acknowledgement of the alpha’s strength and leadership role, other members of… Continue Reading

AndroGel manufacturer stirs up undue concern over “low-T”

Posted in Androgel, Lawsuits

As lawsuits concerning the testosterone therapy drug AndroGel have recently been filed, a great deal of information has come to light concerning the marketing of that product. Here is an excerpt from one of the current AndroGel lawsuits: “In 2000, when the FDA approved AndroGel, the company announced that the market was ‘four to five… Continue Reading

February 2014 – AndroGel Lawsuit Filed in Federal Court

Posted in Androgel, Lawsuits

WARNING: Research shows AndroGel (AbbVie, Inc., Abbott Laboratories, Inc.) is overprescribed and can lead to “serious medical problems, including life threatening cardiac events, strokes, and thrombolytic events.” AndroGel is a topically-applied gel containing testosterone at concentrations of either 1% or 1.62% used by patients suffering from hypogonadism, or “low-testosterone”.  While this condition does persist in… Continue Reading